FDA inspection
Mark Dacey, M.D.: FDA inspection ending Nov 8, 2024
FDA inspection 1253974 · Official Action Indicated (OAI) · Denver, CO
Key facts
| Inspection ID | 1253974 |
|---|---|
| Firm | Mark Dacey, M.D. |
| FEI number | 3031610524 |
| Address | 425 S Cherry St Ste 907 |
| City | Denver |
| State | CO |
| ZIP | 80246 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Nov 8, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
| Warning letter | 722942 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data